About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Kalytera Announces Intention to Seek Amendment of Secured Convertible Debentures Due December 2019
December 20, 2019
Kalytera Announces Extension of Maturity Date of Promissory Note
December 16, 2019
Kalytera Reports Third Quarter 2019 Financial Results
December 2, 2019
Published Studies Provide Further Support For Kalytera’s Program Evaluating CBD in GVHD
November 22, 2019
Kalytera Announces Closing of Final Tranche of Private Placement of Common Shares and Common Share Purchase Warrants and Amendments to Secured Convertible Debenture Units
October 30, 2019
Kalytera Provides Update on Private Placement of Common Shares and Common Share Purchase Warrants
October 21, 2019
Kalytera Terminates Plan to Acquire CBD Extraction Facility
October 17, 2019
View all News and Insights
Browse by Year
2019
2018
2017
2016
2015
